{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:54Z","timestamp":1786991154400,"version":"build-2736575974"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jaad.2020.08.082","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T04:37:10Z","timestamp":1598416630000},"page":"e43-e44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Minimum requirements for reporting clinical trials evaluating the therapeutic potential of platelet-rich plasma"],"prefix":"10.1016","volume":"84","author":[{"given":"Khan","family":"Sharun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit M.","family":"Pawde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.08.082_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.07.006","article-title":"Evaluation of platelet-rich plasma as a treatment for androgenetic alopecia: a randomized controlled trial","author":"Shapiro","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.08.082_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.06.1021","article-title":"The effect of platelet-rich plasma on female androgenetic alopecia: a randomized controlled trial","author":"Dubin","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.08.082_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/14712598.2020.1798925","article-title":"Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system","author":"Kon","year":"2020","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2020.08.082_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/09537104.2020.1729013","article-title":"Studies on platelet rich plasma\u2014new editorial policy for \u201cPlatelets\u201d","volume":"3","author":"Harrison","year":"2020","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.jaad.2020.08.082_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jaad.2019.04.037","article-title":"Platelet-rich plasma and its utility in medical dermatology: a systematic review","volume":"81","author":"Hesseler","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220324798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220324798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:57:10Z","timestamp":1759273030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220324798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0190962220324798"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.08.082","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimum requirements for reporting clinical trials evaluating the therapeutic potential of platelet-rich plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.08.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.07.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}